Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and -independent mechanisms.

Villarino AV, Gallo E, Abbas AK.

J Immunol. 2010 Dec 1;185(11):6461-71. doi: 10.4049/jimmunol.1001343. Epub 2010 Oct 25.

2.

Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Hu X, Ivashkiv LB.

Immunity. 2009 Oct 16;31(4):539-50. doi: 10.1016/j.immuni.2009.09.002. Review.

3.

Interleukin-27 in T cell immunity.

Iwasaki Y, Fujio K, Okamura T, Yamamoto K.

Int J Mol Sci. 2015 Jan 27;16(2):2851-63. doi: 10.3390/ijms16022851. Review.

4.

More than just a T-box: the role of T-bet as a possible biomarker and therapeutic target in autoimmune diseases.

Ji N, Sosa RA, Forsthuber TG.

Immunotherapy. 2011 Mar;3(3):435-41. doi: 10.2217/imt.10.111. Review.

5.

Th17 cytokines and the gut mucosal barrier.

Blaschitz C, Raffatellu M.

J Clin Immunol. 2010 Mar;30(2):196-203. doi: 10.1007/s10875-010-9368-7. Epub 2010 Feb 2. Review.

6.

Keratin 17 as a therapeutic target for the treatment of psoriasis.

Fu M, Wang G.

J Dermatol Sci. 2012 Sep;67(3):161-5. doi: 10.1016/j.jdermsci.2012.06.008. Epub 2012 Jun 23. Review.

PMID:
22795618
7.

Advances in understanding the anti-inflammatory properties of IL-27.

Stumhofer JS, Hunter CA.

Immunol Lett. 2008 May 15;117(2):123-30. doi: 10.1016/j.imlet.2008.01.011. Epub 2008 Mar 3. Review.

8.

Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.

van Hamburg JP, Tas SW.

J Autoimmun. 2017 Dec 15. pii: S0896-8411(17)30801-6. doi: 10.1016/j.jaut.2017.12.006. [Epub ahead of print] Review.

9.

A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.

Stadhouders R, Lubberts E, Hendriks RW.

J Autoimmun. 2017 Dec 21. pii: S0896-8411(17)30803-X. doi: 10.1016/j.jaut.2017.12.007. [Epub ahead of print] Review.

10.

TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity.

Rubtsova K, Marrack P, Rubtsov AV.

Cell Immunol. 2015 Apr;294(2):80-3. doi: 10.1016/j.cellimm.2014.12.002. Epub 2014 Dec 13. Review.

11.

T-bet: a bridge between innate and adaptive immunity.

Lazarevic V, Glimcher LH, Lord GM.

Nat Rev Immunol. 2013 Nov;13(11):777-89. doi: 10.1038/nri3536. Epub 2013 Oct 11. Review.

PMID:
24113868
12.

Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases.

Lai Y, Dong C.

Int Immunol. 2016 Apr;28(4):181-8. doi: 10.1093/intimm/dxv063. Epub 2015 Nov 6. Review.

13.

Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice.

Bolland S, Garcia-Sastre A.

J Exp Med. 2009 Aug 3;206(8):1647-51. doi: 10.1084/jem.20091507. Epub 2009 Jul 27. Review.

14.

Transgenic modelling of cytokine polarization in the lung.

Dela Cruz CS, Kang MJ, Cho WK, Lee CG.

Immunology. 2011 Jan;132(1):9-17. doi: 10.1111/j.1365-2567.2010.03376.x. Epub 2010 Nov 23. Review.

15.

Interleukin-25 (or IL-17E): a new IL-17 family member with growth factor/inflammatory actions.

Kempuraj D, Frydas S, Conti P, Kandere- Grzybowska K, Boucher W, Letourneau R, Madhappan B, Huang SH, Sugimoto K, Papadopoulou NG, Christodoulou S, Theoharides TC.

Int J Immunopathol Pharmacol. 2003 Sep-Dec;16(3):185-8. Review. No abstract available.

PMID:
14611719
16.

Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.

Mourik BC, Lubberts E, de Steenwinkel JEM, Ottenhoff THM, Leenen PJM.

Front Immunol. 2017 Apr 5;8:294. doi: 10.3389/fimmu.2017.00294. eCollection 2017. Review.

17.

Age-Associated B Cells: A T-bet-Dependent Effector with Roles in Protective and Pathogenic Immunity.

Rubtsova K, Rubtsov AV, Cancro MP, Marrack P.

J Immunol. 2015 Sep 1;195(5):1933-7. doi: 10.4049/jimmunol.1501209. Review.

18.

Anti-cytokine vaccines and the immunotherapy of autoimmune diseases.

Wraith DC.

Eur J Immunol. 2006 Nov;36(11):2844-8. Review.

Supplemental Content

Support Center